Common use of Other Licensee Termination Clause in Contracts

Other Licensee Termination. Licensee shall also have the right to terminate this Agreement in its entirety, in its sole discretion, as follows: (i) After First Commercial Sale in the Territory, without cause upon eighteen (18) months prior written notice to Coherus; or (ii) At any time if the aggregate expenses for which Licensee is responsible pursuant to Section 4.1(d)(i) (Global RA Study) and Section 4.1(d)(ii) (Clinical Trials) are reasonably expected to exceed [***]; or (iii) At any time if the aggregate expenses for which Licensee is responsible pursuant to Section 4.1(d)(ii)(3) (Process Development and Manufacture Supporting Clinical Trials and Launch) are reasonably expected to exceed [***]; or (iv) If by [***], the Manufacturing Cost exceeds [***] for one (1) filled, finished, released, labeled dosage form [***]; provided, however, such Manufacturing Cost shall be adjusted each January 1 occurring after the Effective Date [***]; or (v) If by [***], the Manufacturing Cost exceeds [***] for one (1) filled, finished, released, labeled dosage form [***]; provided, however, such Manufacturing Cost shall be adjusted each January 1 occurring after the Effective Date [***].

Other Licensee Termination. Licensee shall also have the right to terminate this Agreement in its entirety, in its sole discretion, as follows: (i) After First Commercial Sale in the Territory, without cause upon eighteen (18) months prior written notice to Coherus; or (ii) At any time if the aggregate expenses for which Licensee is responsible pursuant to Section 4.1(d)(i) (for the Global RA Study) Study and Section 4.1(d)(ii) (Clinical Trials) Trials are reasonably expected to exceed [***]; or (iii) At any time if the aggregate expenses for which Licensee is responsible pursuant to Section 4.1(d)(ii)(3) (for Process Development and Manufacture Supporting Clinical Trials and Launch) Launch are reasonably expected to exceed [***]; or (iv) If by [***], the Manufacturing Cost exceeds [***] for one (1) filled, finished, released, labeled dosage form [***]; provided, however, such Manufacturing Cost shall be adjusted each January 1 occurring after the Effective Date [***]; or (v) If by [***], the Manufacturing Cost exceeds [***] for one (1) filled, finished, released, labeled dosage form [***]; provided, however, such Manufacturing Cost shall be adjusted each January 1 occurring after the Effective Date [***].